Johnson & Johnson buy Erste Group Bank AG
Start price
23.07.25
/
50%
€142.54
Target price
23.07.26
-
Performance (%)
59.67%
End price
24.07.26
€227.60
Summary
This prediction ended on 24.07.26 with a price of €227.60. The BUY prediction by Erste_Group_Bank_AG for Johnson & Johnson saw massive gains of 59.67%. Erste_Group_Bank_AG has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Johnson & Johnson | 0.379% | 0.379% | 50.067% |
| iShares Core DAX® | 0.437% | 5.640% | 7.806% |
| iShares Nasdaq 100 | 1.057% | 0.282% | 27.239% |
| iShares Nikkei 225® | 1.769% | 0.406% | 49.266% |
| iShares S&P 500 | 0.368% | 1.920% | 22.336% |
Comments by Erste_Group_Bank_AG for this prediction
In the thread Johnson & Johnson diskutieren
Johnson & Johnson (NYSE: JNJ) was upgraded by analysts at Erste Group Bank AG from a "hold" rating to a "buy" rating.
Ratings data for JNJ provided by MarketBeat
In the thread Trading Johnson & Johnson
Die von Erste_Group_Bank_AG gewählte maximale Laufzeit wurde überschritten